Governance
The Manchester Cancer Research Centre (MCRC) was established in The University of Manchester in close partnership with The Christie NHS Foundation Trust and Cancer Research UK, and has links to other Trusts conducting cancer research in Manchester. The MCRC follows a federation model which facilitates active participation and contribution from relevant research groups within the partnership.
The MCRC federation model compliments the multidisciplinary and interlinked nature of cancer research and patient care in Manchester
The key stakeholders within the MCRC are involved in governance of the Centre and in strategic decision-making. A clear structure has been developed that supports and encourages open two-way communication, ensuring that the MCRC is able to reflect the needs of each partner organisation individually while focussing on the overarching ambition and aims of the Centre.
Key groups within the governance structure of the MCRC include the University Board, the Steering Board and the Joint Research Strategy Group.
University Strategy Board Membership
The University Board is responsible to the Board of Governors of The University of Manchester for the direction and management of the MCRC. The Director of the MCRC is responsible to the Board for the overall management of the Centre.
| Professor Rod Coombs (Chair) | Deputy President & Deputy Vice-Chancellor, The University of Manchester |
| Professor Martin Humphries | Vice-President and Dean of Faculty of Life Sciences, The University of Manchester |
| Professor Nic Jones | Director, MCRC and Chief Scientist, CR-UK |
| Stephen Mole | Director of Finance, The University of Manchester |
| Professor Ian Jacobs | Vice-President and Dean of Faculty of Medical & Human Sciences, The University of Manchester |
| Professor Colin Bailey | Vice-President and Dean of Faculty of Engineering & Physical Sciences, The University of Manchester |
The Steering Board brings together the key partners (The University of Manchester, The Christie NHS Foundation Trust and Cancer Research UK) to discuss issues within the MCRC and those relating to its key partnerships.
| Dr Michael Oglesby (Chair) | Founder & Chairman, Bruntwood (commercial property company) |
| Lord Keith Bradley | Chairman, The Christie Board and Special Advisor, The University of Manchester |
| Mike Farrar | Chief Executive, NHS Confederation |
| Dr Chris Harrison | Medical Director, The Christie |
| Professor Martin Humphries | Vice-President and Dean of Faculty of Life Sciences, The University of Manchester |
| Professor Nic Jones | Director, MCRC and Chief Scientist, CR-UK |
| Harpal Kumar | Chief Executive, Cancer Research UK |
| Stephen Mole | Director of Finance, The University of Manchester |
| Professor Ian Jacobs | Vice-President and Dean of Faculty of Medical & Human Sciences |
| Professor John Radford | Director of Research & Development, The Christie |
| Professor Dame Nancy Rothwell | President & Vice-Chancellor, The University of Manchester |
| Caroline Shaw | Chief Executive, The Christie |
| David Scott | Director of Science Funding |
Joint Research Strategy Group Membership
The Joint Research Strategy Group develops the combined research strategy of the MCRC and The Christie NHS Foundation Trust and identifies steps for its delivery.
| Professor Nic Jones (Chair) | Director, MCRC and Chief Scientist, CR-UK |
| Angela Ball | Research & Development Manager, The Christie |
| Professor Nigel Bundred | Professor of Surgical Oncology, University Hospital of South Manchester NHS Foundation Trust |
| Professor Noel Clarke | Professor of Urological Oncology, Faculty of Medical & Human Sciences and Consultant Urological Surgeon, The Christie and Hope Hospital |
| Dr Richard Cowan | Consultant in Clinical Oncology and Clinical Lead for Education, The Christie |
| Professor Caroline Dive | Senior Group Leader, Paterson Institute |
| Professor Simon Gaskell | Vice-President (Research), The University of Manchester and Director, Michael Barber Centre for Mass Spectrometry |
| Professor Iain Hagan | Senior Group Leader, Paterson Institute |
| Professor Robert Hawkins | Director of Medical Oncology, Faculty of Medical & Human Sciences and The Christie |
| Professor Tony Howell | Director, Breakthrough Breast Cancer Research Unit and Professor of Medical Oncology, The Christie and Faculty of Medical and Human Sciences |
| Professor Andrew Hughes | Discovery Medicine Director, Clinical, AstraZeneca and Co-Director of MRes in Translational Medicine |
| Professor Tim Illidge | CR-UK Senior Clinical Research Fellow, Faculty of Medical & Human Sciences & Consultant in Clinical Oncology, The Christie |
| Professor Alan Jackson | Professor of Radiology, Faculty of Medical & Human Sciences, The University of Manchester |
| Professor Gordon Jayson | Professor of Medical Oncology, Faculty of Medical & Human Sciences and Consultant in Medical Oncology |
| Professor Henry Kitchener | Professor of Gynaecological Oncology and Consultant Gynaecological Oncologist, Central |
| Dr Donald Ogilvie | Head of Drug Discovery, Paterson Institute |
| Professor John Radford | Director of Research & Development, The Christie |
| Professor Malcolm Ranson | Director, Derek Crowther Clinical Trials Unit, The Christie |
| Professor Nigel Scrutton | Associate Dean for Research, Faculty of Life Sciences, The University of Manchester |
| Professor Peter Stern | Senior Group Leader, Paterson Institute |
| Professor Ian Stratford | Dean for Research, School of Pharmacy & Pharmaceutical Sciences |
| Professor Charles Streuli | Research Director, Breakthrough Breast Cancer Research Unit and Professor of Cell Biology, Faculty of Life Sciences |
| Dr Stephen Taylor | CR-UK Senior Cancer Research Fellow, Faculty of Life Sciences |
| Professor Tony Whetton | Head of School of Cancer and Enabling Sciences, Faculty of Medical & Human Sciences |
| Professor Ashley Woodcock | Head of School of Translational Medicine, Faculty of Medical & Human Sciences |